COVID-19: a user's guide, status of the art, and an original proposal to terminate viral recurrence (211 views)
Hepatology (ISSN: 0026-4806linking, 1827-1669electronic), 2021 Feb; 112(1): 144-152.
Export to BibTeX Export to EndNote
Paper type: Journal Article,
Impact factor: 3.031, 5-year impact factor: 1.515
Url: Not available.
Keywords: Covid-19 Complications Drug Therapy Epidemiology Therapy , Carboxymethylcellulose Sodium Analogs, Derivatives Therapeutic Use , Cytokine Release Syndrome Etiology , Humans , Immunization, Passive , Interferon Inducers Therapeutic Use , Mucocutaneous Lymph Node Syndrome Etiology , Physical Distancing , Poly I-C Therapeutic Use , Polylysine Analogs, Practice Guidelines As Topic , Double-Stranded Drug Effects , Viral Drug Effects , Recurrence , Sars-Cov-2 Classification Genetics Pathogenicity , Secondary Prevention,
Affiliations:
*** IBB - CNR ***
Independent Academic Gastroenterologist, Turin General Hospitals, Turin, Italy - actis_g@libero.it.
Department of Medical Sciences, University of Turin, Turin, Italy.
Institute for Biostructure and Bioimaging, National Research Council, Molecular Biotechnology Center, Turin, Italy.
Unit of Gastroenterology, Molinette-SGAS Hospital, Turin, Italy.
References:
Not available.
Hepatology (ISSN: 0026-4806linking, 1827-1669electronic), 2021 Feb; 112(1): 144-152.
Export to BibTeX Export to EndNote
Paper type: Journal Article,
Impact factor: 3.031, 5-year impact factor: 1.515
Url: Not available.
Keywords: Covid-19 Complications Drug Therapy Epidemiology Therapy , Carboxymethylcellulose Sodium Analogs, Derivatives Therapeutic Use , Cytokine Release Syndrome Etiology , Humans , Immunization, Passive , Interferon Inducers Therapeutic Use , Mucocutaneous Lymph Node Syndrome Etiology , Physical Distancing , Poly I-C Therapeutic Use , Polylysine Analogs, Practice Guidelines As Topic , Double-Stranded Drug Effects , Viral Drug Effects , Recurrence , Sars-Cov-2 Classification Genetics Pathogenicity , Secondary Prevention,
Affiliations:
*** IBB - CNR ***
Independent Academic Gastroenterologist, Turin General Hospitals, Turin, Italy - actis_g@libero.it.
Department of Medical Sciences, University of Turin, Turin, Italy.
Institute for Biostructure and Bioimaging, National Research Council, Molecular Biotechnology Center, Turin, Italy.
Unit of Gastroenterology, Molinette-SGAS Hospital, Turin, Italy.
References:
Not available.
COVID-19: a user's guide, status of the art, and an original proposal to terminate viral recurrence
The world is now entering its 9th month of combat against a pandemic of deadly pneumonia. Started out from China in December 2019, the disease has been declared as caused by infection with a so far unknown RNA Coronavirus of the respiratory family, then named severe acute respiratory syndrome coronavirus (SARS)-CoV-2. In the absence of a vaccine, and with scientists still struggling for an effective therapy, COVID-19 (the SARS-dependent syndrome) carries up to now, a death toll of more than 590,000 (July 18,2020) undermining jobs and finance of contemporary society in all continents. Social distancing, the only measure hitherto shown to restrain virus spread, has been progressively loosened from May 2020 in some countries, leaving us in the fear of repeat attacks from the unchecked virus. We discuss the problem and propose to tentatively boost the anti-virus cell machinery by using lab-made viral mimics to engage cell receptors.
The world is now entering its 9th month of combat against a pandemic of deadly pneumonia. Started out from China in December 2019, the disease has been declared as caused by infection with a so far unknown RNA Coronavirus of the respiratory family, then named severe acute respiratory syndrome coronavirus (SARS)-CoV-2. In the absence of a vaccine, and with scientists still struggling for an effective therapy, COVID-19 (the SARS-dependent syndrome) carries up to now, a death toll of more than 590,000 (July 18,2020) undermining jobs and finance of contemporary society in all continents. Social distancing, the only measure hitherto shown to restrain virus spread, has been progressively loosened from May 2020 in some countries, leaving us in the fear of repeat attacks from the unchecked virus. We discuss the problem and propose to tentatively boost the anti-virus cell machinery by using lab-made viral mimics to engage cell receptors.
COVID-19: a user's guide, status of the art, and an original proposal to terminate viral recurrence
No results. |
COVID-19: a user's guide, status of the art, and an original proposal to terminate viral recurrence
Other filter: ([btitle,keywords] "Covid-19 Complicatio ...
Schijns V, Majhen D, Van Der Ley P, Thakur A, Summerfield A, Berisio R, Nativi C, Fernández-tejada A, Alvarez-dominguez C, Gizurarson S, Zamyatina A, Molinaro A, Rosano C, Jakopin Ž, Gursel I, Mcclean S
* Rational Vaccine Design in Times of Emerging Diseases: The Critical Choices of Immunological Correlates of Protection, Vaccine Antigen and Immunomodulation (270 views)
Pharmaceutics (ISSN: 1999-4923linking, 1999-4923electronic), 2021 Apr 6; 13(4): N/D-N/D.
Impact Factor: 6.321
View Export to BibTeX Export to EndNote
Longo DL
* Immunization against ROS1 by DNA Electroporation Impairs K-Ras-Driven Lung Adenocarcinomas (144 views)
Vaccines (ISSN: 2076-393xlinking), 2020 Apr 6; 8(2): N/D-N/D.
Impact Factor: 4.93
View Export to BibTeX Export to EndNote
Leiria Campo V, Riul TB, Oliveira Bortot L, Martins-teixeira MB, Fiori Marchiori M, Iaccarino E, Ruvo M, Dias-baruffi M, Carvalho I
* A Synthetic MUC1 Glycopeptide Bearing betaGalNAc-Thr as a Tn Antigen Isomer Induces the Production of Antibodies against Tumor Cells (1628 views)
Chembiochem (ISSN: 1439-4227, 1439-7633, 1439-4227linking), 2017 Mar 16; 18(6): 527-538.
Impact Factor: 2.774
View Export to BibTeX Export to EndNote
Longo DL, Dastrù W, Consolino L, Espak M, Arigoni M, Cavallo F, Aime S
* Cluster analysis of quantitative parametric maps from DCE-MRI: Application in evaluating heterogeneity of tumor response to antiangiogenic treatment (569 views)
Magn Reson Imaging (ISSN: 0730-725x), 2015; 33(6): 725-736.
Impact Factor: 1.98
View Export to BibTeX Export to EndNote
Cammisa M, Correra A, Andreotti G, Cubellis MV
* Fabry_CEP: a tool to identify Fabry mutations responsive to pharmacological chaperones (493 views)
Orphanet Journal Of Rare Diseases (ISSN: 1750-1172), 2013 Jul 24; 8: 111-111.
Impact Factor: 3.958
View Export to BibTeX Export to EndNote
Marotta V, Ramundo V, Camera L, Del Prete M, Fonti R, Esposito R, Palmieri G, Salvatore M, Vitale M, Colao A, Faggiano A
* Sorafenib in advanced iodine-refractory differentiated thyroid cancer: Efficacy, safety and exploratory analysis of role of serum thyroglobulin and FDG-PET (562 views)
Clin Endocrinol (ISSN: 0300-0664, 1365-2265, 1365-2265electronic), 2013 May; 78(5): 760-767.
Impact Factor: 3.353
View Export to BibTeX Export to EndNote
Galdiero S, Vitiello M, Finamore E, Mansi R, Galdiero M, Morelli G, Tesauro D
* Activation of monocytic cells by immunostimulatory lipids conjugated to peptide antigens (636 views)
Molecular Biosystems (ISSN: 1742-206x), 2012; 8(12): 3166-3177.
Impact Factor: 3.35
View Export to BibTeX Export to EndNote
* Rational Vaccine Design in Times of Emerging Diseases: The Critical Choices of Immunological Correlates of Protection, Vaccine Antigen and Immunomodulation (270 views)
Pharmaceutics (ISSN: 1999-4923linking, 1999-4923electronic), 2021 Apr 6; 13(4): N/D-N/D.
Impact Factor: 6.321
View Export to BibTeX Export to EndNote
Longo DL
* Immunization against ROS1 by DNA Electroporation Impairs K-Ras-Driven Lung Adenocarcinomas (144 views)
Vaccines (ISSN: 2076-393xlinking), 2020 Apr 6; 8(2): N/D-N/D.
Impact Factor: 4.93
View Export to BibTeX Export to EndNote
Leiria Campo V, Riul TB, Oliveira Bortot L, Martins-teixeira MB, Fiori Marchiori M, Iaccarino E, Ruvo M, Dias-baruffi M, Carvalho I
* A Synthetic MUC1 Glycopeptide Bearing betaGalNAc-Thr as a Tn Antigen Isomer Induces the Production of Antibodies against Tumor Cells (1628 views)
Chembiochem (ISSN: 1439-4227, 1439-7633, 1439-4227linking), 2017 Mar 16; 18(6): 527-538.
Impact Factor: 2.774
View Export to BibTeX Export to EndNote
Longo DL, Dastrù W, Consolino L, Espak M, Arigoni M, Cavallo F, Aime S
* Cluster analysis of quantitative parametric maps from DCE-MRI: Application in evaluating heterogeneity of tumor response to antiangiogenic treatment (569 views)
Magn Reson Imaging (ISSN: 0730-725x), 2015; 33(6): 725-736.
Impact Factor: 1.98
View Export to BibTeX Export to EndNote
Cammisa M, Correra A, Andreotti G, Cubellis MV
* Fabry_CEP: a tool to identify Fabry mutations responsive to pharmacological chaperones (493 views)
Orphanet Journal Of Rare Diseases (ISSN: 1750-1172), 2013 Jul 24; 8: 111-111.
Impact Factor: 3.958
View Export to BibTeX Export to EndNote
Marotta V, Ramundo V, Camera L, Del Prete M, Fonti R, Esposito R, Palmieri G, Salvatore M, Vitale M, Colao A, Faggiano A
* Sorafenib in advanced iodine-refractory differentiated thyroid cancer: Efficacy, safety and exploratory analysis of role of serum thyroglobulin and FDG-PET (562 views)
Clin Endocrinol (ISSN: 0300-0664, 1365-2265, 1365-2265electronic), 2013 May; 78(5): 760-767.
Impact Factor: 3.353
View Export to BibTeX Export to EndNote
Galdiero S, Vitiello M, Finamore E, Mansi R, Galdiero M, Morelli G, Tesauro D
* Activation of monocytic cells by immunostimulatory lipids conjugated to peptide antigens (636 views)
Molecular Biosystems (ISSN: 1742-206x), 2012; 8(12): 3166-3177.
Impact Factor: 3.35
View Export to BibTeX Export to EndNote
7 Records (6 excluding Abstracts).
Total impact factor: 26.666 (22.708 excluding Abstracts).
Total 5 year impact factor: 22.15 (16.77 excluding Abstracts).
Total impact factor: 26.666 (22.708 excluding Abstracts).
Total 5 year impact factor: 22.15 (16.77 excluding Abstracts).
211 views. Last view on Monday 07 October 2024, 14:00:19
ibb.cnr.it
